Search Results 741-750 of 19261 for Hemoglobin

  1. Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery - Mayo Clinic

    Hemoglobin (HgB) >8.5 g/dL; Bilirubin ≤3.0 x upper limit of normal (ULN); SGOT (AST) ≤2.5 x ULN, if subject has HCC or liver metastases ≤5 x UL; SGPT (ALT) ...

  2. Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways - Mayo Clinic

    Clinical laboratory data include: fasting plasma glucose ≥ 100mg/dL, plasma glucose of ≥ 140mg/dL two hours after a 75g glucose load, or hemoglobin A1C ≥ 5.7 ...

  3. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

    Hemoglobin ≥9.0 g/dL;; Total bilirubin ULN;; NOTE: If total bilirubin is out of range then direct bilirubin must be ≤ULN. Alanine transaminase (ALT) 2.5 x ...

  4. Tips to reduce stroke in the diverse communities - Mayo Clinic News Network

    Obtain a hemoglobin A1C, which measures the average blood sugar level over the past three months, with a goal of less than 7%. Be screened for obstructive ...

  5. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    Hemoglobin >= 10 g/dL; Platelets >= 100 x 10^9/L; Total serum bilirubin =< institutional upper limit of normal (ULN); Alanine aminotransferase (ALT) and ...

  6. A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    ... hemoglobin ) ≤ 40% of predicted at the screening visit; Pulmonary arterial hypertension (PAH) as determined by right heart catheterization or on PAH ...

  7. Publications - Stanimir Vuk-Pavlovic, Ph.D. - Mayo Clinic

    From hemoglobin structure to cancer immunotherapy: A very personal account. Period Biol. 2003 Sep; 105(3):201-5. Antica M, Kusic B, Hranilovic D, Dietz AB ...

  8. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

    Anemia is required for trial entry (defined as hemoglobin < 10g/dL or transfusion dependent [having needed a transfusion anytime in the past 6 months]) ...

  9. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL. Hemoglobin = ______;; Total bilirubin < 1.5 x upper limit of normal (ULN), or < 2.5 x ULN if patient has Gilbert syndrome or ...

  10. A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW) - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL (Use of erythropoietic stimulating factors and red blood cell [RBC] transfusion per institutional guidelines is allowed, however the ...